Cargando…

Transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma

Hepatic hemangiomas are common benign liver tumors. While the majority are small and require no treatment, giant hemangiomas are characterized as measuring greater than 4-6 cm in size and may require intervention. Surgical resection and enucleation have been described historically as the treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolger, Kevin, Choudhary, Moaz M., Kouri, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619328/
https://www.ncbi.nlm.nih.gov/pubmed/36324832
http://dx.doi.org/10.1016/j.radcr.2022.09.095
_version_ 1784821249620312064
author Bolger, Kevin
Choudhary, Moaz M.
Kouri, Brian
author_facet Bolger, Kevin
Choudhary, Moaz M.
Kouri, Brian
author_sort Bolger, Kevin
collection PubMed
description Hepatic hemangiomas are common benign liver tumors. While the majority are small and require no treatment, giant hemangiomas are characterized as measuring greater than 4-6 cm in size and may require intervention. Surgical resection and enucleation have been described historically as the treatment for giant hemangiomas requiring intervention. Additionally, limited data exists about the treatment of hemangiomas measuring greater than 20 cm, particularly in regards to transarterial chemoembolization. We present a case of a super-giant hemangioma measuring greater than 20 cm treated with transarterial chemoembolization alone.
format Online
Article
Text
id pubmed-9619328
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96193282022-11-01 Transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma Bolger, Kevin Choudhary, Moaz M. Kouri, Brian Radiol Case Rep Case Report Hepatic hemangiomas are common benign liver tumors. While the majority are small and require no treatment, giant hemangiomas are characterized as measuring greater than 4-6 cm in size and may require intervention. Surgical resection and enucleation have been described historically as the treatment for giant hemangiomas requiring intervention. Additionally, limited data exists about the treatment of hemangiomas measuring greater than 20 cm, particularly in regards to transarterial chemoembolization. We present a case of a super-giant hemangioma measuring greater than 20 cm treated with transarterial chemoembolization alone. Elsevier 2022-10-28 /pmc/articles/PMC9619328/ /pubmed/36324832 http://dx.doi.org/10.1016/j.radcr.2022.09.095 Text en © 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Bolger, Kevin
Choudhary, Moaz M.
Kouri, Brian
Transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma
title Transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma
title_full Transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma
title_fullStr Transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma
title_full_unstemmed Transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma
title_short Transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma
title_sort transarterial chemoembolization as the primary treatment for a super-giant hepatic hemangioma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619328/
https://www.ncbi.nlm.nih.gov/pubmed/36324832
http://dx.doi.org/10.1016/j.radcr.2022.09.095
work_keys_str_mv AT bolgerkevin transarterialchemoembolizationastheprimarytreatmentforasupergianthepatichemangioma
AT choudharymoazm transarterialchemoembolizationastheprimarytreatmentforasupergianthepatichemangioma
AT kouribrian transarterialchemoembolizationastheprimarytreatmentforasupergianthepatichemangioma